Skip to product information
1 of 1

Elabscience

SKU:E-AB-F1039S-50Tests

ER780 Anti-Human CD45 Antibody[9.4]

ER780 Anti-Human CD45 Antibody[9.4]

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
The ER780 Anti-Human CD45 Antibody[9.4] is a highly specialized and meticulously developed product that serves as an essential tool in the field of immunology. This antibody, with its unique specificity towards the CD45 antigen, offers unparalleled accuracy and reliability in various research applications.

Crafted with utmost precision, the ER780 Anti-Human CD45 Antibody[9.4] exhibits exceptional binding affinity towards the CD45 antigen, a transmembrane protein found on the surface of all human leukocytes. This antibody's remarkable specificity ensures minimal cross-reactivity, enabling researchers to confidently explore the intricacies of human immune cell populations.

The ER780 Anti-Human CD45 Antibody[9.4] is designed to facilitate a wide range of experimental techniques, including flow cytometry, immunohistochemistry, and immunoprecipitation. Its versatility allows for comprehensive analysis of leukocyte subpopulations, aiding in the understanding of immune responses, disease progression, and therapeutic interventions.

With its robust performance and consistent results, the ER780 Anti-Human CD45 Antibody[9.4] is an indispensable asset for researchers in the fields of immunology, oncology, and infectious diseases. Its exceptional quality and reliability make it an ideal choice for both academic and industrial laboratories seeking to advance their understanding of human immune system dynamics.

In summary, the ER780 Anti-Human CD45 Antibody[9.4] stands as a pinnacle of scientific innovation, offering researchers an invaluable tool to unravel the complexities of human immune cell populations. Its exceptional specificity, versatility, and reliability make it an indispensable asset in the pursuit of groundbreaking discoveries in the field of immunology.
View full details